120 related articles for article (PubMed ID: 34837450)
1. MEOX1 suppresses the progression of lung cancer cells by inhibiting the cell-cycle checkpoint gene CCNB1.
Xiao X; Rui B; Rui H; Ju M; Hongtao L
Environ Toxicol; 2022 Mar; 37(3):504-513. PubMed ID: 34837450
[TBL] [Abstract][Full Text] [Related]
2. MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer.
Sun L; Yuan H; Burnett J; Gasparyan M; Zhang Y; Zhang F; Yang Z; Ran Y; Sun D
Int J Med Sci; 2019; 16(1):68-74. PubMed ID: 30662330
[No Abstract] [Full Text] [Related]
3. MicroRNA‑718 serves a tumor‑suppressive role in non‑small cell lung cancer by directly targeting CCNB1.
Wang S; Sun H; Zhan X; Wang Q
Int J Mol Med; 2020 Jan; 45(1):33-44. PubMed ID: 31746372
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of ZIC5 promotes proliferation in non-small cell lung cancer.
Sun Q; Shi R; Wang X; Li D; Wu H; Ren B
Biochem Biophys Res Commun; 2016 Oct; 479(3):502-509. PubMed ID: 27663664
[TBL] [Abstract][Full Text] [Related]
5. A pancancer analysis of the oncogenic role of cyclin B1 (CCNB1) in human tumors.
Dai P; Xiong L; Wei Y; Wei X; Zhou X; Zhao J; Tang H
Sci Rep; 2023 Sep; 13(1):16226. PubMed ID: 37758792
[TBL] [Abstract][Full Text] [Related]
6. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
7. RNF168 suppresses the cancer stem cell-like traits of nonsmall cell lung cancer cells by mediating RhoC ubiquitination.
Rong G; Pan Z; Ding M; Wang L
Environ Toxicol; 2022 Mar; 37(3):603-611. PubMed ID: 34873829
[TBL] [Abstract][Full Text] [Related]
8. Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer.
Fang Y; Yu H; Liang X; Xu J; Cai X
Cancer Biol Ther; 2014 Sep; 15(9):1268-79. PubMed ID: 24971465
[TBL] [Abstract][Full Text] [Related]
9. FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1.
Chai N; Xie HH; Yin JP; Sa KD; Guo Y; Wang M; Liu J; Zhang XF; Zhang X; Yin H; Nie YZ; Wu KC; Yang AG; Zhang R
Biochem Biophys Res Commun; 2018 Jun; 500(4):924-929. PubMed ID: 29705704
[TBL] [Abstract][Full Text] [Related]
10. The role of MEOX1 in non-neoplastic and neoplastic diseases.
Zeng G; Liu X; Su X; Wang Y; Liu B; Zhou H; Wang Y; Li F
Biomed Pharmacother; 2023 Feb; 158():114068. PubMed ID: 36495659
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding HOXA11-AS knockdown suppresses the progression of non-small cell lung cancer by regulating miR-3619-5p/SALL4 axis.
Xia H; Niu Q; Ding Y; Zhang Z; Yuan J; Jin W
J Mol Histol; 2021 Aug; 52(4):729-740. PubMed ID: 34050851
[TBL] [Abstract][Full Text] [Related]
12. Silencing of MEOX1 Gene Inhibits Proliferation and Promotes Apoptosis of LNCaP Cells in Prostate Cancer.
Zhu ZY; Wang XL; Li DP
Cancer Biother Radiopharm; 2019 Mar; 34(2):91-102. PubMed ID: 30543460
[TBL] [Abstract][Full Text] [Related]
13. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of hsa‑miR661‑3p on non‑small cell lung cancer in vivo and in vitro.
Lu J; Gu X; Liu F; Rui Z; Liu M; Zhao L
Oncol Rep; 2019 May; 41(5):2987-2996. PubMed ID: 30896844
[TBL] [Abstract][Full Text] [Related]
15. miR-1271 promotes non-small-cell lung cancer cell proliferation and invasion via targeting HOXA5.
Wang Y; Xu L; Jiang L
Biochem Biophys Res Commun; 2015 Mar; 458(3):714-719. PubMed ID: 25686496
[TBL] [Abstract][Full Text] [Related]
16. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
17. MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R.
Wen XP; Ma HL; Zhao LY; Zhang W; Dang CX
Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):78-85. PubMed ID: 26025408
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MEG8 promotes tumor progression of non-small cell lung cancer via regulating miR-107/CDK6 axis.
Liu Y; Li L; Shang P; Song X
Anticancer Drugs; 2020 Nov; 31(10):1065-1073. PubMed ID: 32649368
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
